Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Multi-Center Non-Inferiority Trial of UI-EWD (Nexpowder™) vs. Conventional Treatment as First-Line Endoscopic Therapy for Patients With High-Risk Nonvariceal Upper Gastrointestinal Bleeding (TREET)

NCT06188585 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.

NCT NCT06188585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06188585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Multi-Center Non-Inferiority Trial of UI-EWD (Nexpowder™) vs. Conventional Treatment as First-Line Endoscopic Therapy for Patients With High-Risk Nonvariceal Upper Gastrointestinal Bleeding (TREET)
Lead sponsor
Medtronic - MITG
Phase
Not applicable
Overall status
Recruiting
Start date
June 21, 2024
Completion date
September 30, 2029
Enrollment
278 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute gastrointestinal bleeding